Increasing antimicrobial resistance in nosocomial pathogens; multidrug-resistant extensively drug-resistant and pandrug-resistant Acinetobacter baumannii
Journal Title: Journal of Microbiology and Infectious Diseases - Year 2014, Vol 4, Issue 1
Abstract
Objective:The aim of this study was to determine the antimicrobial susceptibility of Acinetobacter baumannii strains,which were isolated from nosocomial infections and compare the changes in resistance rates of isolates over time. Methods:Acinetobacter spp. strains isolated from hospitalized patients diagnosed with nosocomial infection at Cumhuriyet University Hospital between 2007 and 2011 were included in the study. Isolate identification and antibiotic susceptibility test were performed using an automated system according to the Clinical and Laboratory Standards Institute guidelines. Results:In total, 454 Acinetobacter spp . strains were included in this study. A. baumannii was the most frequently isolated Acinetobacter species . Imipenem and meropenem resistance were determined to be 31.9% and 33.7%, respectively,and 74.4%, 78.0%, 76.7%, 46.6%, 62.4%, 66.8%, 61.3% and 53.9% of isolates were resistant to piperacillin-tazobactam,ceftazidime, cefepim, amikacin, gentamicin, ciprofloxacin, levofloxacin and tetracycline respectively. The resistance rates of multidrug-resistant (MDR), extensively drug-resistant (XDR), and pandrug-resistant (PDR) A. baumannii were 50.2%, 28.5%, and 14.0%, respectively. Changes in MDR, XDR and PDR rates over time were examined. Importantly, PDR A. baumannii have been reached dangerous levels over time. Conclusion:A. baumannii is one of the most important pathogen, particularly in a nosocomial setting. Increasing resistance rates of this group to all antibiotics will likely lead to increased treatment failure in the future.J Microbiol Infect Dis 2014;4(1): 7-12 Key words:Acinetobacter baumannii, antimicrobial resistance, nosocomial nfections
Authors and Affiliations
Cem Çelik, Mustafa Gözel, Fatma Dayı, Nazif Elaldı, Esra Gültürk
Keywords
Related Articles
- EP ID EP110208
- DOI 10.5799/ahinjs.02.2014.01.0116
- Views 116
- Downloads 0
An Audit of Staphylococcus aureus Bacteraemia Treatment in a UK District General Hospital
Objective: Recent guidelines from Healthcare Improvement Scotland recommend that uncomplicated Staphylococcus aureus bacteraemia (SAB) be treated with effective antibiotics for at least 14 days. This audit aimed to see w...
Tüberküloz menenjiti için Cobas Amplicor MTB ve Rotorgene Real Time PCR’ın tanı değeri: 6 yıllık retrospektif çalışma
Amaç: Tüberküloz menejiti (TBM), tüberkülozun (TB) en şiddetli ve öldürücü formudur. TBM’nin bakteriyolojik tanısı zor ve zaman alıcıdır. Bu nedenle, hastaların çoğu sadece klinik ve beyin omurilik sıvısı (BOS)’nın özell...
In-vitro susceptibility of linezolid against methicillin resistant Staphylococcus aureus at a tertiary care hospital in Pakistan
Objective: Methicillin resistant Staphylococcus aureus is a major nosocomial pathogen causing significant morbidity and mortality. The aim of this study was to evaluate the in vitro activity of linezolid against methicil...
Comparative Evaluation of In-vitro Synergy Testing Methods in Carbapenem-Resistant Acinetobacter Species
Objective: There is an increasing incidence of Acinetobacter species causing serious hospital acquired infections such as blood stream infections (BSI), catheter associated urinary tract infections (CAUTI) and lower resp...
Can miliary tuberculosis be an indicator for tuberculous meningitis? Evaluation of the twenty-five adult cases with meningitis accompanied by miliary tuberculosis
Objective: This study aimed to compare the characteristics of the tuberculous meningitis (TBM) patients with and without miliary tuberculosis (TB). Methods: Twenty-five patients with miliary TB of 160 patients with TBM...